Vesper Bio ApS
32879861ActiveA clinical-stage biotech company developing oral therapies for neurodegeneration.
Oversikt
- 7
- Ansatte
- Ukjent
- Omsetning
- 2010
- Grunnlagt
Nøkkelbeslutningstakere
Anders Nykjær
Founder
Jacob Falck Hansen
Chief Executive Officer
John King-Underwood
Medicinal Chemistry
Graham Wynne
Medicinal Chemistry
+1 flere kontakter i Funnelfeedr
Beskrivelse
Vesper Bio is a clinical-stage biotechnology company dedicated to pioneering research in Sortilin biology. The organization focuses on developing innovative oral therapies for patients suffering from devastating and fatal disorders, specifically targeting Frontotemporal Degeneration. Founded on deep...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Ukjent
- Juridisk form
- APS
- MVA-nummer
- DK32879861
Beslutningstakere
5 kontakter i FunnelfeedrAnders Nykjær
Founder
Jacob Falck Hansen
Chief Executive Officer
Andre kontakter
John King-Underwood
Medicinal Chemistry
Graham Wynne
Medicinal Chemistry
Andy Mulvaney
Business Development
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrNeumirna Therapeutics ApS
9 ansatteDeveloping miRNA-based therapies to treat complex neurological disease root causes.
CONTERA PHARMA A/S
19 ansatteDanish biotech company developing innovative RNA therapeutics for neurological disorders.
Vertanical Denmark ApS
23 ansatteInnovative biopharmaceutical company developing advanced cannabinoid-based chronic pain therapies.
Pephexia Therapeutics ApS
5 ansatteDeveloping innovative peptide-based therapies for treating cachexia and sarcopenia.
PAREXEL DENMARK A/S
20 ansatteLeading global clinical research organization accelerating life-changing medical treatments worldwide.
Utforsk mer
Spørsmål om Vesper Bio ApS
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo